1
0
0
(1 - 19 von 21
)
1346 Antibodies against GlycoTargets as novel platform ...The Journal for ImmunoTherapy of Cancervon P Kehler · 2022
jitc.bmj.com
Patrik Kehler, · Theresa Neumann, · Anika Jaekel, · Manon Weis, · Johanna Gellert, · Antje Danielczyk, · Evelyn Hartung, · Timo Lischke, ... Patrik Kehler, · Theresa Neumann, · Anika Jaekel, · Manon Weis, · Johanna Gellert, · Antje Danielczyk, · Evelyn Hartung, · Timo Lischke, ...
1462 Antibodies specifically recognizing ...The Journal for ImmunoTherapy of Cancervon T Neumann · 2023
jitc.bmj.com
Timo Lischke,; Naomi Kast,; Lisa Weiss,; Luisa Willmann,; Stephanie Gurka,; Sophie Marinoff,; Johanna Gellert,; Sven Barke,; Antje Danielczyk and; Patrik Kehler. Timo Lischke,; Naomi Kast,; Lisa Weiss,; Luisa Willmann,; Stephanie Gurka,; Sophie Marinoff,; Johanna Gellert,; Sven Barke,; Antje Danielczyk and; Patrik Kehler.
712 Preclinical characterization of GT-00A x IL15: A novel...
jitc.bmj.com
von A Jaekel · — Anika Jaekel, · Patrik Kehler, · Timo Lischke, · Christoph Goletz, · Anke Flechner, · Antje Danielczyk and · Johanna Gellert.
712 Preclinical characterization of GT-00A x IL15ProQuestvon A Jaekel · · Zitiert von: 1
search.proquest.com
Anika Jaekel*, Patrik Kehler, Timo Lischke, Christoph Goletz, Anke Flechner,. Antje Danielczyk, Johanna Gellert. Glycotope GmbH, Berlin, Germany. Background ... Anika Jaekel*, Patrik Kehler, Timo Lischke, Christoph Goletz, Anke Flechner,. Antje Danielczyk, Johanna Gellert. Glycotope GmbH, Berlin, Germany. Background ...
712 Preclinical characterization of GT-00A x IL15 - ProQuest
www.proquest.com
von A Jaekel · — Anika Jaekel*, Patrik Kehler, Timo Lischke, Christoph Goletz, Anke Flechner,. Antje Danielczyk, Johanna Gellert. Glycotope GmbH, Berlin, Germany. › openview › 1.pdf
Abstract 316: Carbohydrate-dependent protein binding antibodies ...
aacrjournals.org
Timo Lischke; ... Citation Format: Patrik Kehler, Anika Jaekel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Evelyn Hartung, Lisa Weiß, Manon Weis, ... › article
Abstract 2879: Preclinical characterization of GT-00A x IL15aacrjournals.org
aacrjournals.org
von P Kehler · — Citation Format: Patrik Kehler, Anika Jaekel, Johanna Gellert, Christoph Goletz, Timo Lischke, Anke Flechner, Antje Danielczyk, Theresa Neumann. von P Kehler · — Citation Format: Patrik Kehler, Anika Jaekel, Johanna Gellert, Christoph Goletz, Timo Lischke, Anke Flechner, Antje Danielczyk, Theresa Neumann.
GlycoTargetsGlycotope
www.glycotope.com
... Timo Lischke, Evelyn Hartung, Naomi Kast, Manon Weiske, Marianne Morche, Lisa Weiß, Johanna Gellert, Antje Danielczyk, Patrik Kehler. Theresa.Neumann Timo Lischke, Evelyn Hartung, Naomi Kast, Manon Weiske, Marianne Morche, Lisa Weiß, Johanna Gellert, Antje Danielczyk, Patrik Kehler. Theresa.Neumann ...
712 Preclinical characterization of GT-00A x IL15: A novel...
www.proquest.com
Anika Jaekel*, Patrik Kehler, Timo Lischke, Christoph Goletz, Anke Flechner,. Antje Danielczyk, Johanna Gellert. Glycotope GmbH, Berlin, Germany.
Article Versions NotesMDPI
www.mdpi.com
Gellert, Johanna, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Anke Flechner, Laura Dix, Alexandra Günzl, and Patrik Kehler "GT ... Gellert, Johanna, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Anke Flechner, Laura Dix, Alexandra Günzl, and Patrik Kehler "GT ...
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody...
figshare.com
Authors. Christoph Goletz. Timo Lischke. Ulf Harnack. Phillip Schiele. Antje Danielczyk. Johanna Rühmann. Steffen Goletz ...
Glyco-Engineered Anti-Human Programmed Death Europe PMCeuropepmc.org › article › pmc › pmc
europepmc.org
Christoph Goletz,*† Timo Lischke,† Ulf Harnack, Phillip Schiele, Antje Danielczyk, Johanna Rühmann, and Steffen Goletz. Author information Article notes ...
GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based ...Gale
go.gale.com
AP — Citation metadata. Authors: Johanna Gellert, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke and Anke Flechner. Date: Jan AP — Citation metadata. Authors: Johanna Gellert, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke and Anke Flechner. Date: Jan
Create a SciFeed alert for new publicationsMDPI
www.mdpi.com
By following authors. Johanna Gellert. Anika Jäkel. Antje Danielczyk. Christoph Goletz. Timo Lischke. Anke Flechner. Laura Dix. Alexandra Günzl. Patrik Kehler ... By following authors. Johanna Gellert. Anika Jäkel. Antje Danielczyk. Christoph Goletz. Timo Lischke. Anke Flechner. Laura Dix. Alexandra Günzl. Patrik Kehler ...
GT001--antiLewis-Y-antibody-with-superior-finespecificity ...Larvol Delta
delta.larvol.com
AP — Alexandra Günzl; Anika Jäkel; Anke Flechner; Antje Danielczyk; Christoph Goletz; Johanna Gellert; Laura Dix; Patrik Kehler; Timo Lischke AP — Alexandra Günzl; Anika Jäkel; Anke Flechner; Antje Danielczyk; Christoph Goletz; Johanna Gellert; Laura Dix; Patrik Kehler; Timo Lischke.
Glyco-Engineered Anti-Human Programmed Death-Ligand ...Europe PMCvon C Goletz · · Zitiert von: 27
europepmc.org
... Timo Lischke,† Ulf Harnack, Phillip Schiele, Antje Danielczyk, Johanna Rühmann, and Steffen Goletz. Author information Article notes Copyright and License Timo Lischke,† Ulf Harnack, Phillip Schiele, Antje Danielczyk, Johanna Rühmann, and Steffen Goletz. Author information Article notes Copyright and License ...
Using glyco-engineered cells with flexible expression of tumor ...aacrjournals.org
aacrjournals.org
von P Kehler · — Timo Lischke; ... Format: Patrik Kehler, Naomi Kast, Manon Weiske, Stephanie Gurka, Timo Lischke, Johanna Gellert, Antje Danielczyk.
l‐fucose, a sugary regulator of antitumor immunity and ...Researcher App
www.researcher-app.com
Johanna Rühmann, Ulf Harnack, Steffen Goletz, Timo Lischke, Antje Danielczyk, Christoph Goletz, Phillip Schiele. Unbookmark paper Bookmark paper.
The Role of Cell Surface Glycans in Activation of Multiple Modes of ...www.zora.uzh.ch › eprint
www.zora.uzh.ch
· by Christoph Goletz, Timo Lischke, Ulf Harnack, Phillip Schiele, Antje Danielczyk, Johanna Rühmann, Steffen Goletz.
Alle Infos zum Namen "Timo Lischke"
sortiert nach Relevanz / Datum